Risk stratification and treatment strategies for prostate cancer are determined based on patients’ clinical characteristics, such as age, prostate-specific antigen (PSA), imaging findings such as magnetic resonance imaging (MRI), and preoperative prostate biopsy Gleason grade group (GGG) (2). The gene discussed is KLK3; the disease is prostate carcinoma.